|
1）Chertow GM, Levin NW, Beck GJ, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010; 363: 2287-300
|
|
|
|
2）Weinhandl ED, Nieman KM, Gilbertson DT, et al. Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. Am J Kidney Dis. 2015; 65: 98-108
|
|
|
|
|
|
3）Suri RS, Li L, Nesrallah GE. The risk of hospitalization and modality failure with home dialysis. Kidney Int. 2015; 88: 360-8
|
|
|
|
|
|
4）Maduell F, Moreso F, Pons M, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013; 24: 487-97
|
|
|
|
|
|
5）Wang AY, Ninomiya T, Al-Kahwa A, et al. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials. Am J Kidney Dis. 2014; 63: 968-78
|
|
|
|
|
|
6）Flythe JE, Inrig JK, Shafi T, et al. Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis. Am J Kidney Dis. 2013; 61: 966-74
|
|
|
|
|
|
7）Park J, Rhee CM, Sim JJ, et al. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int. 2013; 84: 795-802
|
|
|
|
|
|
8）Shafi T, Sozio SM, Bandeen-Roche KJ, et al. Predialysis systolic BP variability and outcomes in hemodialysis patients. J Am Soc Nephrol. 2014; 25: 799-809
|
|
|
|
|
|
9）Lertdumrongluk P, Streja E, Rhee CM, et al. Changes in pulse pressure during hemodialysis treatment and survival in maintenance dialysis patients. Clin J Am Soc Nephrol. 2015; 10: 1179-91
|
|
|
|
|
|
10）Fahim MA, Hayen A, Horvath AR, et al. N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients. Clin J Am Soc Nephrol. 2015; 10: 620-9
|
|
|
|
|
|
11）Madsen LH, Ladefoged S, Corell P, et al. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int. 2007; 71: 548-54
|
|
|
|
|
|
12）Naito T, Masaki T, Shimizu Y, et al. [N-terminal pro brain natriuretic peptide predicts hospitalization of hemodialysis patients for cardiovascular disease]. Nihon Jinzo Gakkai Shi. 2011; 53: 633-41
|
|
|
|
|
13）Shafi T, Zager PG, Sozio SM, et al. Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis. 2014; 64: 443-51
|
|
|
|
|
|
14）Sakaguchi Y, Fujii N, Shoji T, et al. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int. 2014; 85: 174-81
|
|
|
|
|
|
15）Komaba H, Taniguchi M, Wada A, et al. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int. 2015; 88: 350-9
|
|
|
|
|
|
16）Kuragano T, Matsumura O, Matsuda A, et al. Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients. Kidney Int. 2014; 86: 845-54
|
|
|
|
|
|
17）Wang Z, Nicholls SJ, Rodriguez ER, et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med. 2007; 13: 1176-84
|
|
|
|
|
|
18）Koeth RA, Kalantar-Zadeh K, Wang Z, et al. Protein carbamylation predicts mortality in ESRD. J Am Soc Nephrol. 2013; 24: 853-61
|
|
|
|
|
|
19）Drechsler C, Kalim S, Wenger JB, et al. Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease. Kidney Int. 2015; 87: 1201-8
|
|
|
|
|
|
20）Cao XS, Chen J, Zou JZ, et al. Association of indoxyl sulfate with heart failure among patients on hemodialysis. Clin J Am Soc Nephrol. 2015; 10: 111-9
|
|
|
|
|
|
21）Suliman ME, Johnson RJ, García-López E, et al. J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis. 2006; 48: 761-71
|
|
|
|
|
|
22）Latif W, Karaboyas A, Tong L, et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol. 2011; 6: 2470-7
|
|
|
|
|
|
23）Xia X, He F, Wu X, et al. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis. Am J Kidney Dis. 2014; 64: 257-64
|
|
|
|
|
|
24）Drechsler C, Schneider A, Gutjahr-Lengsfeld L, et al. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients. Am J Kidney Dis. 2014; 63: 988-96
|
|
|
|
|
|
25）Chang TI, Nam JY, Shin SK, et al. Low triiodothyronine syndrome and long-term cardiovascular outcome in incident peritoneal dialysis patients. Clin J Am Soc Nephrol. 2015; 10: 975-82
|
|
|
|
|
|
26）Holzer M, Schilcher G, Curcic S, et al. Dialysis modalities and HDL composition and function. J Am Soc Nephrol. 2015; 26: 2267-76
|
|
|
|
|
|
27）Silbernagel G, Genser B, Drechsler C, et al. HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients. J Am Soc Nephrol. 2015; 26: 484-92
|
|
|
|
|
|
28）Kopecky C, Genser B, Drechsler C, et al. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis. Clin J Am Soc Nephrol. 2015; 10: 224-31
|
|
|
|
|
|
29）Haycock PC, Heydon EE, Kaptoge S, et al. Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2014; 349: g4227
|
|
|
|
|
|
30）Ramírez R, Carracedo J, Soriano S, et al. Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. Am J Kidney Dis. 2005; 45: 353-9
|
|
|
|
|
|
31）Makarov VL, Hirose Y, Langmore JP. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell. 1997; 88: 657-66
|
|
|
|
|
|
32）Tahara H, Kusunoki M, Yamanaka Y, et al. G-tail telomere HPA: simple measurement of human single-stranded telomeric overhangs. Nat Methods. 2005; 2: 829-31
|
|
|
|
|
|
33）Hirashio S, Nakashima A, Doi S, et al. Telomeric g-tail length and hospitalization for cardiovascular events in hemodialysis patients. Clin J Am Soc Nephrol. 2014; 9: 2117-22
|
|
|
|
|